Concepedia

Antibody targeting of CD24 efficiently retards growth and influences cytokine milieu in experimental carcinomas

A. V. Salnikov, Niko P. Bretz, Claudia Perne, John Hazin, Sandro Keller, Mina Fogel, Ingrid Herr, Thomas Schlange, Gerhard Moldenhauer, Peter Altevogt

British Journal of Cancer · 2013 · 79 citations · 27 references

DOIFull text

Open access

Abstract

Our data demonstrate that targeting of CD24 could be beneficial for the anti-cancer treatment combined with standard chemotherapy regimes.

References

27

Marketed therapeutic antibodies compendium

Janice M. Reichert · mAbs · 2012 · 365 citations · Full text

, , +16

CD24, a Mucin-Type Glycoprotein, Is a Ligand for P-Selectin on Human Tumor Cells

Silke Aigner, Zev Sthoeger, Mina Fogel et al. · Blood · 1997 · 324 citations · Full text

CD24 Expression Causes the Acquisition of Multiple Cellular Properties Associated with Tumor Growth and Metastasis

Petra Baumann, Natascha Cremers, Frans G. M. Kroese et al. · Cancer Research · 2005 · 322 citations

CD24 mediates rolling of breast carcinoma cells on P‐selectin

Silke Aigner, Carroll L. Ramos, Ali Hafezi‐Moghadam et al. · The FASEB Journal · 1998 · 282 citations

Antibody-based therapeutics to watch in 2011

Janice M. Reichert · mAbs · 2011 · 234 citations · Full text

, , +16